IPO Issue Details
Issue Price / Price Band₹54 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size2,000 Shares per Lot
Total Issue Size38,18,000 shares (aggregating up to ₹20.62 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 13 Feb 2025
Subscription CloseMon, 17 Feb 2025
Anchor AllotmentWed, 12 Feb 2025
Basis of AllotmentTue, 18 Feb 2025
Initiation of RefundsWed, 19 Feb 2025
Credit of Shares to DematWed, 19 Feb 2025
Listing DateFri, 21 Feb 2025
UPI Mandate Deadline2025-02-17
Application & Investment Details
Retail — Min (1 Lots)₹1,08,000 — 2,000 shares
Retail — Max (13 Lots)₹1,404,000 (13 Lots)
HNI — Min (2 Lots)₹2,16,000 — 4,000 shares
EPS (Pre-IPO)₹5.37
EPS (Post-IPO)₹4.75
P/E Ratio (Pre-IPO)10.05x
P/E Ratio (Post-IPO)11.36x
Net Offer to Public36,26,000 shares (aggregating up to ₹19.58 Cr)
Reserved for Market Maker1,92,000 shares (aggregating up to ₹1.04 Cr)
Pre-IPO Promoter Holding97,95,000 shares
Post-IPO Promoter Holding1,36,13,000 shares
About Shanmuga Hospital Ltd
Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital.Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions.Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation.Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team.Hospital Units:Shanmuga Pharmacy & Diagnostics:The hospital operates Shanmuga Pharmacy, providing medications to OPD and IPD patients. Shanmuga Diagnostics offers reliable pathology services for accurate medical evaluations and treatment planning.Shanmuga Clinics:The hospital extends services through Shanmuga Clinics, providing specialized consultations and treatments in Salem. Critical patients are transferred to the main hospital for advanced care when necessary.Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine.As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors.Competitive Strengths:Oncology PresenceRich experience of promoters of over four decadesCost Affordable to Regional PopulationSpecialized Equipment like LINAC, CATHLAB, MRI, MODULAR OTTie-up with Government and Private Insurance Companies
Objects of the Issue
Shanmuga Hospital Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding Capital Expenditure towards Purchase of additional Medical Equipment
2
General Corporate Purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding
97,95,000 shares
Post-IPO Promoter Holding
1,36,13,000 shares